APL-2501

N/A

Report date: 2025/11/12 16:25:15

Base Information

Drug NameAPL-2501
Drug Alias NameAPL-2501APL2501
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CLDN6Anti-Claudin-9
TargetsClaudin 6Claudin-9
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAsieris Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAsieris Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A